GIM
BSX icon

Groesbeck Investment Management’s Boston Scientific BSX Stock Holding History

Groesbeck Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Hold
500
– – 0.03% 87
2026
Q1 		$31K Hold
500
– – 0.06% 83
2025
Q4 		$48K Buy
+500
New +$49K 0.09% 80

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Groesbeck Investment Management's BSX Position: Q2 2026 in Review

Groesbeck Investment Management held its Boston Scientific (BSX) position steady in Q2 2026 at 500 shares worth $21K. The position accounts for 0.03% of the portfolio, ranked #87.

Groesbeck Investment Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $48K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Groesbeck Investment Management held 500 shares of Boston Scientific worth $21K as of Q2 2026.
  • Groesbeck Investment Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.03% of Groesbeck Investment Management's portfolio in Q2 2026, its #87 holding.
  • Groesbeck Investment Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Groesbeck Investment Management's Boston Scientific position peaked at $48K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.